Modified release compositions of nafamostat and methods of using same
The controlled release beads with nafamostat and acrylate/methacrylate polymers address the challenge of uncontrolled drug absorption by ensuring sustained enzyme inhibition, reducing overdose risk through extended release.
US12636253B2Active Publication Date: 2026-05-26ENSYSCE BIOSCIENCES INC
Patent Information
- Authority / Receiving Office
- US · United States
- Patent Type
- Patents(United States)
- Current Assignee / Owner
- ENSYSCE BIOSCIENCES INC
- Filing Date
- 2022-03-08
- Publication Date
- 2026-05-26
Smart Images
Figure US12636253-D00000_ABST
Abstract
Aspects of the present disclosure include a composition of nafamostat or a pharmaceutically acceptable salt thereof that provides for controlled release of nafamostat or pharmaceutically acceptable salt thereof to a subject for an extended period of time. Compositions according to certain embodiments include a plurality of controlled release beads where each bead includes a core, an active agent layer having nafamostat or a pharmaceutically acceptable salt thereof and a controlled release layer having one or more polymers formulated in an amount sufficient to provide for controlled release of the nafamostat or pharmaceutically 10 acceptable salt thereof. Methods for administering (e.g., orally) the controlled release nafamostat compositions to a subject are also described.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Process for the production of high-molecular weight, polypeptide-like compounds of physiologically or therapeutically active compounds
DE1041052B
Process for the preparation of aminocarboxamides
DE1493824A1
Oxycodone conjugates with lower abuse potential and extended duration of action
EP1782834A2
Homoarginine-prodrugs of amphetamine
EP2433655A2
Psychopharmacologically active peptides
GB1425099A